Spoton Trial Evaluating the Efficacy on BAlance Disorder sYmptoms (STEADY)
Clinical trial NCT03726112 · SUSPENDED
Trial details
- NCT number
- NCT03726112
- Sponsor
- SpotOn Therapeutics Ltd.
- Status
- SUSPENDED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-01
- Primary completion
- 2019-12-01
- Enrollment
- 110
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.